Package 16571-861-25

Brand: olopatadine hydrochloride

Generic: olopatadine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 16571-861-25
Digits Only 1657186125
Product NDC 16571-861
Description

1 CONTAINER in 1 CARTON (16571-861-25) / 2.5 mL in 1 CONTAINER

Marketing

Marketing Status
Marketed Since 2025-05-01
Brand olopatadine hydrochloride
Generic olopatadine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "d6814040-cbb9-4a23-aa29-e3d30bb97efc", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["0988e6e2-59a9-47dc-9386-9e9ea877e6c1"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CONTAINER in 1 CARTON (16571-861-25)  / 2.5 mL in 1 CONTAINER", "package_ndc": "16571-861-25", "marketing_start_date": "20250501"}], "brand_name": "olopatadine hydrochloride", "product_id": "16571-861_d6814040-cbb9-4a23-aa29-e3d30bb97efc", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "16571-861", "generic_name": "olopatadine hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "olopatadine hydrochloride", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA204620", "marketing_category": "ANDA", "marketing_start_date": "20250501", "listing_expiration_date": "20261231"}